TickerGuard
Buy Day today: Poor (44) Weak market breadth · today: Core PCE (August) ≈
CDXS

Codexis Inc

Healthcare · Biotechnology

1.40$ -0.7% vs. previous close Closing price · As of: Sep 23, 2026

Statements

Balance Sheet

Codexis Inc (CDXS) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 120 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet CDXS
Line item Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26
154 137 150 132 148 149 129 138 124 148 129 120
103 93 108 91 113 99 78 89 76 97 80 72
75 65 58 19 37 19 18 27 26 51 37 27
75 65 86 73 90 73 60 66 59 78 66 55
19 20 14 12 17 19 12 16 9.7 11 8.0 7.4
2.3 2.7 2.4 2.2 2.1 1.8 1.8 1.9 1.9 1.8 2.0 1.6
29 – – – – – – – – – – –
2.5 2.5 2.5 2.5 2.5 2.5 2.5 2.5 2.5 2.5 2.5 2.5
63 50 70 71 75 82 79 83 85 97 86 87
38 36 29 31 35 24 21 15 18 25 15 24
6.8 3.8 3.9 4.0 4.1 2.8 2.9 3.0 3.1 2.9 3.3 10
3.1 5.9 3.5 3.7 4.2 2.8 6.0 1.5 2.4 1.6 2.1 2.6
– – 28 28 29 29 29 39 40 40 40 34
92 87 79 61 73 67 50 56 39 51 43 33
-490 -498 -509 -532 -552 -563 -583 -597 -616 -607 -615 -627
69 70 70 70 72 81 82 85 90 91 91 91

Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?